Literature DB >> 15831647

Relation between plasma amino-terminal propeptide of procollagen type III and left ventricular longitudinal strain in essential hypertension.

S H Poulsen1, N H Andersen, L Heickendorff, C E Mogensen.   

Abstract

OBJECTIVE: To investigate whether myocardial fibrosis assessed non-invasively is related to left ventricular (LV) longitudinal systolic function in patients with essential hypertension.
DESIGN: The study consisted of 30 control subjects and 40 patients with hypertension with normal LV ejection fraction. Tissue Doppler echocardiography was performed to assess LV longitudinal systolic strain from the apical views. Mean strain was calculated from the basal and mid segments. Plasma concentrations of the amino-terminal propeptide of type III procollagen (PIIINP) were measured.
RESULTS: In the hypertension group, mean strain was significantly reduced (mean (SD) 13 (6)% v 21 (6)%, p < 0.01) and plasma PIIINP were increased compared with controls (3.0 (0.7) microg/l v 2.1 (0.3) microg/l, p < 0.001). A significant correlation was found between mean strain and PIIINP (r = -0.56, p < 0.001). In patients with abnormal diastolic filling (n = 21) mean strain was reduced compared with patients with normal LV filling (n = 19) (10 (6)% v 15 (6)%, p < 0.01) and the serological marker PIIINP was increased (3.5 (0.6) microg/l v 2.5 (0.5) microg/l, p < 0.001).
CONCLUSIONS: There is a significant association between the extent of myocardial fibrosis and reduced LV longitudinal contractility.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15831647      PMCID: PMC1768864          DOI: 10.1136/hrt.2003.029702

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  26 in total

1.  Myocardial strain by Doppler echocardiography. Validation of a new method to quantify regional myocardial function.

Authors:  S Urheim; T Edvardsen; H Torp; B Angelsen; O A Smiseth
Journal:  Circulation       Date:  2000-09-05       Impact factor: 29.690

2.  Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function.

Authors:  C M O'Connor; W A Gattis; L Shaw; M S Cuffe; R M Califf
Journal:  Am J Cardiol       Date:  2000-10-15       Impact factor: 2.778

3.  Pseudonormal and restrictive filling patterns predict left ventricular dilation and cardiac death after a first myocardial infarction: a serial color M-mode Doppler echocardiographic study.

Authors:  J E Møller; E Søndergaard; S H Poulsen; K Egstrup
Journal:  J Am Coll Cardiol       Date:  2000-11-15       Impact factor: 24.094

4.  Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease.

Authors:  C G Brilla; R C Funck; H Rupp
Journal:  Circulation       Date:  2000-09-19       Impact factor: 29.690

5.  Tissue tracking allows rapid and accurate visual evaluation of left ventricular function.

Authors:  C Pan; R Hoffmann; H Kühl; E Severin; A Franke; P Hanrath
Journal:  Eur J Echocardiogr       Date:  2001-09

6.  Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients.

Authors:  B López; R Querejeta; N Varo; A González; M Larman; J L Martínez Ubago; J Díez
Journal:  Circulation       Date:  2001-07-17       Impact factor: 29.690

7.  Coronary vasodilator capacity and epicardial vessel remodeling in physiological and hypertensive hypertrophy.

Authors:  M Kozàkovà; F Galetta; L Gregorini; G Bigalli; F Franzoni; C Giusti; C Palombo
Journal:  Hypertension       Date:  2000-09       Impact factor: 10.190

8.  Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes.

Authors:  D Vinereanu; N Florescu; N Sculthorpe; A C Tweddel; M R Stephens; A G Fraser
Journal:  Am J Cardiol       Date:  2001-07-01       Impact factor: 2.778

9.  Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study.

Authors:  R B Devereux; M J Roman; J E Liu; T K Welty; E T Lee; R Rodeheffer; R R Fabsitz; B V Howard
Journal:  Am J Cardiol       Date:  2000-11-15       Impact factor: 2.778

10.  Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease.

Authors:  R Querejeta; N Varo; B López; M Larman; E Artiñano; J C Etayo; J L Martínez Ubago; M Gutierrez-Stampa; J I Emparanza; M J Gil; I Monreal; J P Mindán; J Díez
Journal:  Circulation       Date:  2000-04-11       Impact factor: 29.690

View more
  8 in total

Review 1.  Left ventricular function assessment in cirrhosis: Current methods and future directions.

Authors:  Francisco Sampaio; Joana Pimenta
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

2.  The interplay between renin-angiotensin system activation, abnormal myocardial deformation and neurohumoral activation in hypertensive heart disease: a speckle tracking echocardiography study.

Authors:  Ignatios Ikonomidis; Stavros Tzortzis; Argirios Tsantes; Konstantina Ntai; Helen Triantafyllidi; Paraskevi Trivilou; George Katsimaglis; Kleanthi Dima; John Parissis; John Lekakis
Journal:  Int J Cardiovasc Imaging       Date:  2016-10-27       Impact factor: 2.357

Review 3.  Extracellular matrix fibrotic markers in heart failure.

Authors:  Faiez Zannad; Patrick Rossignol; Wafae Iraqi
Journal:  Heart Fail Rev       Date:  2010-07       Impact factor: 4.214

4.  Clinical and echocardiographic correlates of plasma procollagen type III amino-terminal peptide levels in the community.

Authors:  Thomas J Wang; Martin G Larson; Emelia J Benjamin; Deborah A Siwik; Radwan Safa; Chao-Yu Guo; Diane Corey; Johan Sundstrom; Douglas B Sawyer; Wilson S Colucci; Ramachandran S Vasan
Journal:  Am Heart J       Date:  2007-08       Impact factor: 4.749

5.  Assessment of cardiovascular physiology using dobutamine stress cardiovascular magnetic resonance reveals impaired contractile reserve in patients with cirrhotic cardiomyopathy.

Authors:  Francisco Sampaio; Pablo Lamata; Nuno Bettencourt; Sophie Charlotte Alt; Nuno Ferreira; Johannes Tammo Kowallick; Joana Pimenta; Shelby Kutty; José Fraga; Michael Steinmetz; Paulo Bettencourt; Vasco Gama; Andreas Schuster
Journal:  J Cardiovasc Magn Reson       Date:  2015-07-18       Impact factor: 5.364

6.  Early and Quantitative Assessment of Myocardial Deformation in Essential Hypertension Patients by Using Cardiovascular Magnetic Resonance Feature Tracking.

Authors:  Huina Liu; Jiajia Wang; Yukun Pan; Yinghui Ge; Zhiping Guo; Shihua Zhao
Journal:  Sci Rep       Date:  2020-02-27       Impact factor: 4.379

7.  Predictive Value of Collagen Biomarkers for Heart Failure With and Without Preserved Ejection Fraction: MESA (Multi-Ethnic Study of Atherosclerosis).

Authors:  Daniel A Duprez; Myron D Gross; Jorge R Kizer; Joachim H Ix; William G Hundley; David R Jacobs
Journal:  J Am Heart Assoc       Date:  2018-02-23       Impact factor: 5.501

8.  Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction.

Authors:  Akiomi Yoshihisa; Yu Sato; Tetsuro Yokokawa; Takamasa Sato; Satoshi Suzuki; Masayoshi Oikawa; Atsushi Kobayashi; Takayoshi Yamaki; Hiroyuki Kunii; Kazuhiko Nakazato; Shu-Ichi Saitoh; Yasuchika Takeishi
Journal:  ESC Heart Fail       Date:  2017-10-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.